Activin A: Latest developments in Parkinson’s disease research
Parkinson’s disease is one of the most feared neurodegenerative diseases facing Australians. But new findings are giving hope to sufferers and those in the research field. The latest finding centres around Activin A, which may offer anti-inflammatory and neuroprotective effects in mouse models for Parkinson’s disease. Presenter Sam Baran spoke with Professor Bryce Vissel, The Roth Fellow and the Head of the Centre for Neuroscience and Regenerative Medicine at UTS.
Producer: Liane Colwell
